This announcement is a separate document:
石藥集團：自願公告 - 新型冠狀病毒mRNA疫苗(SYS6006) 研究進展的最新情況
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - UPDATE ON THE CLINICAL STUDY PROGRESS OF SARS-CoV-2 mRNA VACCINE (SYS6006)
Aug 23, 2022 17:27
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.